The Timeline Followback reports of psychoactive substance use by drug-abusing patients: Psychometric properties.

Fals‐Stewart, William; O’Farrell, Timothy J.; Freitas, Timothy T.; McFarlin, Susan K.; Rutigliano, Peter

doi:10.1037//0022-006x.68.1.134

Cited by 257 publications

(7 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Little is known regarding the diagnostic accuracy of client self‐report of recent methamphetamine use in clinical treatment populations, even when using a structured assessment of self‐reported use with good psychometric properties for the index test (e.g. TLFB) [ 33 ]. We followed the STARD 2015 standards [ 32 ] for reporting this study.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Diagnostic accuracy for self‐reported methamphetamine use versus oral fluid test as the reference standard in a methamphetamine‐dependent intervention trial population

et al. 2022

View full text Add to dashboard Cite

Aims Treatment of methamphetamine dependence requires monitoring of recent use or abstinence. Self‐report is commonly used for routine monitoring, but the accuracy of self‐report is not established. For the treating clinician, the key accuracy statistic is the negative predictive value (NPV). The study aim was to estimate the NPV of self‐reported non‐use of methamphetamine compared with an oral fluid reference standard. Design, Setting and Participants This study was a secondary (subgroup) analysis from a randomized controlled pharmacotherapy trial. Three Australian outpatient addiction services took part. Particpants were 139 people dependent on methamphetamine. Measurements Weekly oral fluid samples over 12 weeks to determine methamphetamine (and amphetamine) concentrations were used as the reference standard. Self‐report of any methamphetamine use in the previous 7 days by the time‐line follow‐back method was the index test. Standard diagnostic accuracy statistics were calculated for all available paired episodes (n = 1134). Three NPV values were calculated: unadjusted NPV and NPV adjusted for clustering of observations through logistic regression and generalized estimating equation (GEE). We also calculated the NPVs for a range of prevalence rates of methamphetamine use, for the calculated levels of sensitivity and specificity. Findings Sensitivity was 96.4% [95% confidence interval (CI) = 95–97.5], specificity was 63.7% (95% CI = 57.3–69.8) and positive predictive value (PPV) was 90.8% (95% CI = 88.8–92.6). The unadjusted NPV was 82.7% (95% CI = 76.5–87.9), adjusted NPV by logistic regression 82.7% (95% CI = 73.9–91.5) and GEE 76.8% (95% CI = 66.8–86.8). At a methamphetamine use prevalence of 5%, the estimated NPV would be 99.7% (95% CI = 99.6–99.9) and at 95% prevalence, 48.2% (95% CI = 39.6–57.0). Conclusions Self‐report of no recent methamphetamine use appears to be sufficiently accurate to be clinically useful at the expected prevalence rates of methamphetamine use in clinical treatment settings. If generalizable to clinical settings, where these tests are routinely conducted, this may permit a reduction in the frequency and cost of oral fluid assays.

show abstract

Section: Discussionmentioning

confidence: 99%

“…Days of methamphetamine use in the past 7 days was assessed using the time‐line follow‐back (TLFB) method [ 33 ]. Self‐report of any methamphetamine use in the previous 7 days indicated a positive response, and self‐report of no methamphetamine use in the period indicated a negative response.…”

Section: Methodsmentioning

confidence: 99%

Diagnostic accuracy for self‐reported methamphetamine use versus oral fluid test as the reference standard in a methamphetamine‐dependent intervention trial population

et al. 2022

View full text Add to dashboard Cite

show abstract

“…The outcomes, measurements, and corresponding hypotheses are listed in Table 1 . The timeline followback was assessed for 30 days [ 54 ]. Second, health-related quality of life was measured by the World Health Organization Quality of Life Brief Version (WHOQOL-BREF) [ 55 , 56 ].…”

Section: Methodsmentioning

confidence: 99%

Relapse Prevention Group Therapy in Indonesia Involving Peers via Videoconferencing for Substance Use Disorder: Development and Feasibility Study

Siste,

Ophinni,

Hanafi

et al. 2024

JMIR Form Res

View full text Add to dashboard Cite

Background Substance use disorder (SUD) is a major health issue in Indonesia, where several barriers to treatment exist, including inaccessibility to treatment services, stigma, and criminalization of drug issues. Peer involvement and the use of telemedicine to deliver psychotherapy are promising approaches to overcome these barriers. Objective This study aims (1) to describe the development of a new group psychotherapy coprovided by a health care worker and a peer and (2) to evaluate the acceptability, practicality, and preliminary outcomes of the program delivered via videoconferencing in Indonesia. Methods Building upon an established relapse prevention therapy in Japan, we developed a 3-month weekly group therapy module in the Indonesian language. Adjustments were made via focus group discussions with local stakeholders in terms of substance types, understandability, inclusive language, and cultural relevance. A pilot study was conducted to test the new module provided by a peer and a psychiatrist via videoconferencing, termed tele-Indonesia Drug Addiction Relapse Prevention Program (tele-Indo-DARPP), with a pre- and postcontrolled design. We analyzed data from semistructured feedback interviews and outcome measurements, including the number of days using substances and quality of life, and compared the intervention (tele-Indo-DARPP added to treatment as usual [TAU]) and control (TAU only) arms. Results In total, 8 people diagnosed with SUD participated in the pilot study with a mean age of 37 (SD 12.8) years. All were men, and 7 (88%) used sedatives as the primary substance. Collectively, they attended 44 of the 48 tele-Indo-DARPP sessions. A total of 3 out of 4 (75%) preferred telemedicine rather than in-person therapy. Positive acceptability and practicality were shown from qualitative feedback, in which the participants who joined the tele-Indo-DARPP reported that they liked the convenience of joining from home and that they were able to open up about personal matters, received helpful advice from peers, and received support from other participants. Providers reported that they feel the module was provider-friendly, and the session was convenient to join without diminishing rapport-building. Meanwhile, troubles with the internet connection and difficulty in comprehending some terminology in the workbook were reported. The intervention arm showed better improvements in psychological health and anxiety symptoms. Conclusions Group psychotherapy via videoconferencing coprovided by health care workers and peers was acceptable and practical for participants with SUD and service providers in this study. A large-scale study is warranted to examine the effectiveness of the newly developed module in Indonesia.

show abstract

“…Self-reported outcome measures were collected at baseline (pre-intervention) and again at 3-, 6-, 9- and 12-months post-entry. The measures included: the average pain intensity (BPI [ 18 ] ), physical function (ODI; BPI’s pain interference [ 18 ] ), morphine-equivalent dose of prescribed opioids (Timeline Followback method [ 21 , 22 ] ), health-related quality of life (12-item Short Form Survey, SF-12, physical, and mental health components [ 23 ] ), negative affect (Hospital Anxiety Depression Scale, HADS [ 24 ] ), opioid misuse risk (Current Opioid Misuse Measure, Current Opioid Misuse Measure [ 25 ] ), pain catastrophizing (Pain Catastrophizing Scale [ 26 ] ), loneliness (3-item UCLA Loneliness Scale [ 27 ] ), feeling loved (Feeling Loved instrument [ 28 ] ), healthcare utilization and level of productivity (HealthCare Utilization and Productivity Scale [ 29 ] ), and baseline demographics.…”

Section: Methodsmentioning

confidence: 99%

Experiences of adults with opioid-treated chronic low back pain during the COVID-19 pandemic: A cross-sectional survey study

Zgierska,

Burzinski,

Garland

et al. 2023

Medicine

View full text Add to dashboard Cite

This study aimed to evaluate the impact of the COVID-19 pandemic on adults with opioid-treated chronic low back pain (CLBP), an understudied area. Participants in a “parent” clinical trial of non-pharmacologic treatments for CLBP were invited to complete a one-time survey on the perceived pandemic impact across several CLBP- and opioid therapy-related domains. Participant clinical and other characteristics were derived from the parent study’s data. Descriptive statistics and latent class analysis analyzed quantitative data; qualitative thematic analysis was applied to qualitative data. The survey was completed by 480 respondents from June 2020 to August 2021. The majority reported a negative pandemic impact on their life (84.8%), with worsened enjoyment of life (74.6%), mental health (74.4%), pain (53.8%), pain-coping skills (49.7%), and finances (45.3%). One-fifth (19.4%) of respondents noted increased use of prescribed opioids; at the same time, decreased access to medication and overall healthcare was reported by 11.3% and 61.6% of respondents, respectively. Latent class analysis of the COVID-19 survey responses revealed 2 patterns of pandemic-related impact; those with worse pandemic-associated harms (n = 106) had an overall worse health profile compared to those with a lesser pandemic impact. The pandemic substantially affected all domains of relevant health-related outcomes as well as healthcare access, general wellbeing, and financial stability among adults with opioid-treated CLBP. A more nuanced evaluation revealed a heterogeneity of experiences, underscoring the need for both increased overall support for this population and for an individualized approach to mitigate harms induced by pandemic or similar crises.

show abstract

The Timeline Followback reports of psychoactive substance use by drug-abusing patients: Psychometric properties.

Cited by 257 publications

References 25 publications

Diagnostic accuracy for self‐reported methamphetamine use versus oral fluid test as the reference standard in a methamphetamine‐dependent intervention trial population

Diagnostic accuracy for self‐reported methamphetamine use versus oral fluid test as the reference standard in a methamphetamine‐dependent intervention trial population

Relapse Prevention Group Therapy in Indonesia Involving Peers via Videoconferencing for Substance Use Disorder: Development and Feasibility Study

Experiences of adults with opioid-treated chronic low back pain during the COVID-19 pandemic: A cross-sectional survey study

Contact Info

Product

Resources

About